Aprogen Pharmaceuticals Inc (003060) — Net Asset Quality Index
Aprogen Pharmaceuticals Inc (003060) has a Net Asset Quality Index of 52.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩603.42 Billion minus total liabilities of ₩288.27 Billion yields net assets of ₩315.16 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Aprogen Pharmaceuticals Inc's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Aprogen Pharmaceuticals Inc Net Asset Quality Index Over Time (2009–2024)
This chart shows how Aprogen Pharmaceuticals Inc's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2024. As of September 2025, the index stands at 52.2%, representing net assets of ₩315.16 Billion against total assets of ₩603.42 Billion KRW. See Aprogen Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Aprogen Pharmaceuticals Inc (2009–2024)
The table below presents the year-by-year Net Asset Quality Index for Aprogen Pharmaceuticals Inc from 2009 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 003060 market cap overview.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 64.1% | ₩378.69 Billion | ₩590.98 Billion | ₩212.29 Billion | ▲ +1.5 pp |
| 2023 | 62.6% | ₩368.69 Billion | ₩589.40 Billion | ₩220.71 Billion | ▼ -12.1 pp |
| 2022 | 74.6% | ₩510.41 Billion | ₩684.14 Billion | ₩173.73 Billion | ▼ -22.6 pp |
| 2021 | 97.2% | ₩597.18 Billion | ₩614.62 Billion | ₩17.44 Billion | ▼ -0.1 pp |
| 2020 | 97.2% | ₩598.36 Billion | ₩615.31 Billion | ₩16.95 Billion | ▲ +2.1 pp |
| 2019 | 95.2% | ₩347.64 Billion | ₩365.28 Billion | ₩17.65 Billion | ▲ +25.8 pp |
| 2018 | 69.3% | ₩150.51 Billion | ₩217.06 Billion | ₩66.55 Billion | ▲ +20.1 pp |
| 2017 | 49.2% | ₩77.86 Billion | ₩158.27 Billion | ₩80.41 Billion | ▼ -11.5 pp |
| 2016 | 60.7% | ₩78.12 Billion | ₩128.69 Billion | ₩50.57 Billion | ▼ -18.8 pp |
| 2015 | 79.5% | ₩67.75 Billion | ₩85.22 Billion | ₩17.48 Billion | ▲ +6.3 pp |
| 2014 | 73.2% | ₩62.11 Billion | ₩84.83 Billion | ₩22.71 Billion | ▲ +1.0 pp |
| 2013 | 72.3% | ₩56.55 Billion | ₩78.26 Billion | ₩21.71 Billion | ▼ -1.3 pp |
| 2012 | 73.6% | ₩68.51 Billion | ₩93.08 Billion | ₩24.58 Billion | ▲ +10.4 pp |
| 2011 | 63.2% | ₩73.49 Billion | ₩116.33 Billion | ₩42.85 Billion | ▲ +8.8 pp |
| 2010 | 54.4% | ₩42.81 Billion | ₩78.70 Billion | ₩35.89 Billion | ▼ -6.8 pp |
| 2010 | 61.2% | ₩41.38 Billion | ₩67.64 Billion | ₩26.26 Billion | ▲ +18.5 pp |
| 2009 | 42.6% | ₩25.18 Billion | ₩59.07 Billion | ₩33.89 Billion | — |